𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increase in the incidence of non-Hodgkin’s lymphoma, clinical features and long-term follow-up

✍ Scribed by Marta Llanos Muñoz; Remedios Alemán Wallss; Hugo Álvarez-Argüelles Cabrera; Francisco Cáceres Gómez; Juana Oramas Rodríguez; Josefina Cruz Jurado; Manuel Morales González; Javier Dorta Delgado; Norberto Batista López

Book ID
110647037
Publisher
Springer Milan
Year
2001
Tongue
Spanish
Weight
70 KB
Volume
3
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long term follow-up and late complicatio
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-hodgkin's lymphoma
✍ Lynn R. Kong; Cheng-Fang Huang; David Hakimian; Daina Variakojis; Leonard Klein; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

## Background: The aim of this study was to determine the long term outcome and toxicities after the administration of 2-chlorodeoxyadenosine (2-cda) to patients with previously treated, advanced, indolent non-hodgkin's lymphoma (nhl). ## Methods: Twenty-two patients (median age, 55 years) with r

Long term follow-up and late complicatio
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma
✍ Meral Beksaç; Mutlu Arat; Ramazan Idilman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

Is Flow Cytometry a Useful Test? R epresenting a busy flow cytometry laboratory with an annual workload of approximately 1400 acute leukemia and malignant lymphoma cases, we read the article by Naughton et al. 1 with considerable interest. The authors concluded that "flow cytometry of bone marrow as

Long-term follow-up of patients receivin
Long-term follow-up of patients receiving salvage chemotherapy for intermediate and high grade non-Hodgkin's lymphomas
✍ Dr. Raymond H. S. Liang; Edmond K. W. Chiu; T. K. Chan; David Todd; Ronald P. Ng 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 1 views

This is an analysis of the long-term follow-up data of 99 patients receiving HOAP-Bleo, IMVP-16 and PAC as salvage chemotherapy for refractory or relapsed intermediate or high grade non-Hodgkin's lymphomas. Most of the patients received HOAP-Bleo or PAC following failure of initial chemotherapy and

What is the Price of survival in Hodgkin
What is the Price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients
✍ Miltényi Zsófia; Keresztes Katalin; Végh Judit; Székely György; Illés Árpád 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

## Abstract The paper investigates the late complications of cured Hodgkin's lymphoma (HL) patients. Ninety cured HL patients between 1975 and 1994 were examined. The mean ages of patients at the time of diagnosing HL, and the median period of survival after diagnosis were 32 (11–70) years and 18 (